Study on alantolactone-induced differentiation of mesenchymal stem cells into vascular cells
Journal Title: Traditional Medicine Research - Year 2018, Vol 3, Issue 4
Abstract
To promote efficient screening of active angiogenic drugs from traditional medicines, we constructed a human embryonic kidney-293 cell model using vascular endothelial growth factor (VEGF) gene promoter as the drug target. In this model, VEGF gene promoter may regulate the expression of the luciferase reporter gene by responding to the stimulation of drug molecules. This cell model allows rapid and efficient screening of vascular-inducing active components from several drug monomer molecules. Furthermore, we used rat bone marrow mesenchymal stem cells (rMSCs) to conduct a preliminary study on the activity of alantolactone. Using simvastatin as a positive control, we investigated the effects of alantolactone on the expression of vascular-related cell marker molecules such as VEGF and α-smooth muscle actin (α-SMA) in rMSCs. According to our results, 0.1, 1, 3 and 5 μM of alantolactone upregulated the transcriptional luciferase gene activity of VEGF promoter, and a significant difference from that in the control group was observed. Among them, 3μM of alantolactone showed the better effect than that of 3 μM of simvastatin (P = 0.036) and other concentrations of alantolactone and simvastatin showed similar effects. Compared with that in the control group, rMSCs induced with 1μM alantolactone for 3 days showed a significant increase in the relative mRNA expressions of VEGF and α-SMA genes. However, these effect of 5 μM alantolactone were weaker than those of 5 μM simvastatin (P < 0.05); rMSCs treated with 1 μM alantolactone for 3 days showed brighter green fluorescence (FITC marker) of α-SMA and VEGF in situ expression than that observed in the control group and similar fluorescence intensity than that of simvastatin group in an immunoradiometric assay. The above results demonstrate the reliability of the highly efficient system for screening of active drug molecules and confirmed the vascular induction function of alantolactone at the gene and protein levels.
Authors and Affiliations
Yan-Jiao Lu, Qiong Lu, Ruo-Ke Su, Gang Wang, Rui Tan
Keywords
Related Articles
- EP ID EP45226
- DOI 10.12032/TMR201812077
- Views 273
- Downloads 0
Study on an innovative natural drug for Alzheimer's disease reported as a sham
The number of patients with dementia is estimated to be as high as 24 million and is predicted to double every 20 years, i.e., by 2040, leading to a tremendous financial disease burden [1]. Therefore, we urgently need to...
Errata Notice
On page 177, “确认是和 DNM 还是 DN 比较？” was a text comment written by an editor for fact checking purposes. It should have been removed before publishing. We deeply apologize to the readers and the authors of this...
Plant distribution and pharmacological activity of flavonoids
Flavonoids are natural organic compounds that are widely found in nature, their structural types are complex, and they mainly include flavonoids, flavonols, dihydroflavonols, isoflavones, dihydroisoflavones, chalcones, o...
From religious manual to herbal pharmacopoeia: a textual study of the formation and transformation of Shennong’s Classic of Materia Medica
The earliest Ben Cao Jing (Classics of Materia Medica; 25 C.E.–220 C.E.) appeared during the reign of the Han Dynasty (202 B.C.E.–220 C.E.); their origins are traceable to the religious group called Fang Xian Dao. In add...
South Asian medicinal plants and chronic kidney disease
Chronic kidney disease remains as one of the serious health issues in South Asia. The paucity of effective pharmacotherapy targeting the management of chronic kidney disease has led to a search for alternative pharmacolo...